Company Snapshot

Investment Thesis

Agilent Technologies supplies life science and diagnostics instrumentation, consumables, and software. Biopharma, chemical analysis, and diagnostics demand drive recurring revenue.

  • Recurring Consumables: Chemistries and services account for >50% of revenue.
  • BioPharma Focus: LC/MS, CE, and cell analysis tools support biologics development.
  • Digital Lab: OpenLab software and crosslab services improve customer workflows.

Strategic Mix

Life Sciences & Applied Markets Chromatography, mass spec, and spectroscopy instruments
Diagnostics & Genomics Pathology, companion diagnostics, and genomics reagents
Agilent CrossLab Services, consumables, and lab informatics
Geography Mix Balanced revenue from Americas, EMEA, and Asia-Pacific

Mix follows Agilent's reporting segments emphasizing recurring revenue.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Companion Diagnostics

Partnerships with pharma expand regulatory-approved assays.

China Opportunity

Localized manufacturing and service teams capture lab buildout.

Operating Leverage

Scalable SG&A and manufacturing drive margin expansion.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...